In the past week, ZURA stock has gone down by -1.49%, with a monthly gain of 8.88% and a quarterly plunge of -23.02%. The volatility ratio for the week is 13.47%, and the volatility levels for the last 30 days are 15.30% for Zura Bio Ltd The simple moving average for the past 20 days is 17.38% for ZURA’s stock, with a -32.86% simple moving average for the past 200 days.
Is It Worth Investing in Zura Bio Ltd (NASDAQ: ZURA) Right Now?
Additionally, the 36-month beta value for ZURA is 0.25. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ZURA is 18.90M and currently, short sellers hold a 3.32% ratio of that float. The average trading volume of ZURA on April 22, 2024 was 291.44K shares.
ZURA) stock’s latest price update
The stock price of Zura Bio Ltd (NASDAQ: ZURA) has dropped by -10.30 compared to previous close of 3.69. Despite this, the company has seen a fall of -1.49% in its stock price over the last five trading days. Business Wire reported 2024-02-02 that HENDERSON, Nev.–(BUSINESS WIRE)—- $ZURA #TeamZura–Zura Bio today announced participation at several upcoming conferences in February.
Analysts’ Opinion of ZURA
Many brokerage firms have already submitted their reports for ZURA stocks, with Ladenburg Thalmann repeating the rating for ZURA by listing it as a “Buy.” The predicted price for ZURA in the upcoming period, according to Ladenburg Thalmann is $10 based on the research report published on October 10, 2023 of the previous year 2023.
Oppenheimer, on the other hand, stated in their research note that they expect to see ZURA reach a price target of $17. The rating they have provided for ZURA stocks is “Outperform” according to the report published on August 25th, 2023.
Guggenheim gave a rating of “Buy” to ZURA, setting the target price at $20 in the report published on June 22nd of the previous year.
ZURA Trading at 1.07% from the 50-Day Moving Average
After a stumble in the market that brought ZURA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.36% of loss for the given period.
Volatility was left at 15.30%, however, over the last 30 days, the volatility rate increased by 13.47%, as shares surge +14.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.25% lower at present.
During the last 5 trading sessions, ZURA fell by -1.49%, which changed the moving average for the period of 200-days by -54.78% in comparison to the 20-day moving average, which settled at $2.84. In addition, Zura Bio Ltd saw -29.12% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZURA starting from Thiara Parvinder, who sale 2,000,000 shares at the price of $4.00 back on Dec 12 ’23. After this action, Thiara Parvinder now owns 4,801,633 shares of Zura Bio Ltd, valued at $8,000,000 using the latest closing price.
Munshi Amit, the Director of Zura Bio Ltd, purchase 117,647 shares at $4.25 during a trade that took place back on Jun 05 ’23, which means that Munshi Amit is holding 617,640 shares at $500,000 based on the most recent closing price.
Stock Fundamentals for ZURA
The total capital return value is set at -0.78.
Currently, EBITDA for the company is -8.9 million with net debt to EBITDA at 1.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.97.
Conclusion
In conclusion, Zura Bio Ltd (ZURA) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
